1 |
Boz V, Zanchi C, Levantino L, Riccio G, Tommasini A. Druggable monogenic immune defects hidden in diverse medical specialties: Focus on overlap syndromes. World J Clin Pediatr 2022; 11(2): 136-150 [DOI: 10.5409/wjcp.v11.i2.136] [Reference Citation Analysis]
|
2 |
El Jammal T, Jamilloux Y, Gerfaud-Valentin M, Richard-Colmant G, Weber E, Bert A, Androdias G, Sève P. Challenging Mimickers in the Diagnosis of Sarcoidosis: A Case Study. Diagnostics (Basel) 2021;11:1240. [PMID: 34359324 DOI: 10.3390/diagnostics11071240] [Reference Citation Analysis]
|
3 |
Bayless NL, Bluestone JA, Bucktrout S, Butterfield LH, Jaffee EM, Koch CA, Roep BO, Sharpe AH, Murphy WJ, Villani AC, Walunas TL. Development of preclinical and clinical models for immune-related adverse events following checkpoint immunotherapy: a perspective from SITC and AACR. J Immunother Cancer 2021;9:e002627. [PMID: 34479924 DOI: 10.1136/jitc-2021-002627] [Reference Citation Analysis]
|
4 |
Costagliola G, Consolini R. Lymphadenopathy at the crossroad between immunodeficiency and autoinflammation: An intriguing challenge. Clin Exp Immunol 2021;205:288-305. [PMID: 34008169 DOI: 10.1111/cei.13620] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
5 |
Abubakar SD, Ihim SA, Farshchi A, Maleknia S, Abdullahi H, Sasaki T, Azizi G. The role of TNF-α and anti-TNF-α agents in the immunopathogenesis and management of immune dysregulation in primary immunodeficiency diseases. Immunopharmacology and Immunotoxicology. [DOI: 10.1080/08923973.2021.2023173] [Reference Citation Analysis]
|